Efficacy of Lapaquistat Acetate on Blood Cholesterol Levels in Treating Subjects With Hypercholesterolemia
This study has been terminated.
(Overall profile of the compound does not offer significant clinical advantage to patients over currently available lipid lowering agents)
Takeda Global Research & Development Centre (Europe) Ltd.
Information provided by (Responsible Party):
Takeda Global Research & Development Center, Inc. ( Takeda Global Research & Development Centre (Europe) Ltd. )
First received: September 18, 2007
Last updated: May 23, 2012
Last verified: May 2012
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been terminated.|
|Study Completion Date:||May 2008|
|Primary Completion Date:||May 2008 (Final data collection date for primary outcome measure)|